These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8834712)

  • 1. Relevance of 24 H blood pressure profile and sympathetic activity for outcome on short- versus long-acting 1,4-dihydropyridines.
    Ruzicka M; Leenen FH
    Am J Hypertens; 1996 Jan; 9(1):86-94. PubMed ID: 8834712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of cardiac hypertrophy by 1,4 dihydropyridines in hypertensive patients.
    Leenen FH
    J Hypertens Suppl; 1998 Oct; 16(5):S9-15. PubMed ID: 9868999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical relevance of 24 h blood pressure control by 1,4-dihydropyridines.
    Leenen FH
    Am J Hypertens; 1996 Oct; 9(10 Pt 2):97S-104S; discussion 108S-109S. PubMed ID: 8896671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,4-Dihydropyridines versus beta-blockers for hypertension: are either safe for the heart?
    Leenen FH
    Cardiovasc Drugs Ther; 1996 Sep; 10(4):397-402. PubMed ID: 8924051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-versus long-term effects of different dihydropyridines on sympathetic and baroreflex function in hypertension.
    Grassi G; Seravalle G; Turri C; Bolla G; Mancia G
    Hypertension; 2003 Mar; 41(3):558-62. PubMed ID: 12623959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermittent blood pressure control: potential consequences for outcome.
    Leenen FH
    Can J Cardiol; 1999 May; 15 Suppl C():13C-18C. PubMed ID: 10380687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of once-daily antihypertensive drugs on blood pressure, left ventricular mass and sympathetic activity: Nifedipine-GITS versus felodipine-ER versus enalapril.
    Leenen FH; Myers MG; Joyner CD; Toal CB
    Can J Cardiol; 2002 Dec; 18(12):1285-93. PubMed ID: 12518180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of left ventricular hypertrophy in human hypertension.
    Kahan T
    J Hypertens Suppl; 1998 Sep; 16(7):S23-9. PubMed ID: 9855028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of antihypertensive therapies on the sympathetic nervous system.
    de Champlain J; Karas M; Toal C; Nadeau R; Larochelle P
    Can J Cardiol; 1999 Mar; 15 Suppl A():8A-14A. PubMed ID: 10205251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Beta-Blockers in the Treatment of Hypertension.
    Cruickshank JM
    Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central sympathoinhibitory effects of calcium channel blockers.
    Leenen FH; Ruzicka M; Huang BS
    Curr Hypertens Rep; 2001 Aug; 3(4):314-21. PubMed ID: 11470014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent blood pressure control: Potential consequences for outcome.
    Leenen FH
    Can J Cardiol; 1999 May; 15(Suppl C):13C-18C. PubMed ID: 10350687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence.
    Antza C; Stabouli S; Kotsis V
    Vasc Health Risk Manag; 2016; 12():443-451. PubMed ID: 27895487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baroreflexes and cardiovascular regulation in hypertension.
    Head GA
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S7-16. PubMed ID: 8642810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of azelnidipine and amlodipine on sympathetic nerve activity in patients with primary hypertension.
    Inomata J; Murai H; Kaneko S; Hamaoka T; Ikeda T; Kobayashi D; Usui S; Furusho H; Sugiyama Y; Takata S; Takamura M
    J Hypertens; 2014 Sep; 32(9):1898-904. PubMed ID: 24979307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent sympathetic activation during chronic antihypertensive therapy: a potential mechanism for long term morbidity?
    Fu Q; Zhang R; Witkowski S; Arbab-Zadeh A; Prasad A; Okazaki K; Levine BD
    Hypertension; 2005 Apr; 45(4):513-21. PubMed ID: 15738344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of sympathetic nervous activity on regression of cardiac hypertrophy.
    Strauer BE; Bayer F; Brecht HM; Motz W
    J Hypertens Suppl; 1985 Dec; 3(4):S39-44. PubMed ID: 2937889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sympathetic nervous factors, pressure variability and organ damage in arterial hypertension].
    Mancia G; Seravalle G; Grassi G
    Ann Ital Med Int; 1997; 12(4):217-22. PubMed ID: 9773576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.